About NKGEN BIOTECH INC
NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic, and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases using their proprietary SNK (super-activated) platform.
Development of autologous, allogeneic, and CAR-NK natural killer cell therapiesUtilization of proprietary SNK (super-activated) platform for immune cell therapyResearch and clinical trials in neurodegenerative and oncological diseases
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NKGEN BIOTECH INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.